Improving outcomes for patients with cancer by accelerating the development, validation, & accessibility of liquid biopsy assays.

  • Address liquid biopsy disparities today to ensure equity in outcomes tomorrow

    To ensure equity in liquid biopsy access, BLOODPAC's roadmap calls for diverse trials, payer engagement, and patient education to address key barriers.

    READ ARTICLE

  • Improving Cancer Care Requires Payers at the Table

    This white paper highlights the importance of payer engagement in ensuring patient access to liquid biopsy in cancer care.

    READ WHITE PAPER

How We Work

EVIDENCE GENERATION

Align around a framework for evidence generation to bring liquid biopsy into routine clinical practice.

BLOODPAC PORTAL

Enables community storing, sharing and analysis of liquid biopsy datasets for the community.

STAKEHOLDER ENGAGEMENT

Accelerate approval through stakeholder engagement.

“Cancer knows no borders, and neither should innovative technologies that can improve people's lives. BLOODPAC's work to foster a global dialogue on regulatory standards will help accelerate the process of bringing liquid biopsy to clinical settings around the world for patient benefit.”

JENNIFER DICKEY
Head, Regulatory and Quality at Personal Genome Diagnostics

From Our Blog

Group Photo 2024 Q3.JPG
Rob and Jerry.jpg
Copy of DSC09818.JPG
Lauren & Adam.jpg
IMG_6065.jpeg